100 likes | 127 Views
Looking for the best Sirolimus component, look no further than MedicaPharma. Sirolimus (rapamycin) is a powerful macrolide compound that plays a vital role in preventing organ rejection after transplants, treating lymphangioleiomyomatosis, and providing stent coating for cardiac health. Its primary immunosuppressive mechanism targets the mechanistic Target Of Rapamycin (mTOR), inhibiting B and T cell activation by reducing sensitivity to interleukin-2. Approved by the FDA in 1999, Sirolimus is marketed as Rapamune by Pfizer.
E N D
Sirolimus: A Versatile Macrolide Compound for Organ Transplantation, Lung Disease, and Cardiac Health
Research Studies • Tuberous sclerosis complex: Sirolimus shows promise in treating benign tumor growth. • Lymphatic malformation: Topical rapamycin improves symptoms. • Longevity: Sirolimus inhibits aging in various organisms. • SARS-CoV-2: Potential role in reducing cytokine storms and viral replication.
Adverse Effects • Common reactions: Headache, nausea, diarrhea, fever, urinary tract infection, anemia, and more. • Adverse conditions: Diabetes-like symptoms, lung toxicity, reduced immune system function, increased cancer risk, impaired wound healing.